ArticleJournal of the American Heart Association2026
Association of Subclinical Cardiac Remodeling With Incident Cancer in the MESA Cohort.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPatients with established cardiovascular disease have an increased risk of cancer; however, the association between subclinical cardiac remodeling and cancer development remains unclear. We aimed to examine the association between cardiac magnetic resonance imaging-derived measures of subclinical cardiac remodeling and incident cancer in the MESA (Multi-Ethnic Study of Atherosclerosis) cohort.
methodsMultivariable Cox proportional hazards models were used to estimate the association between each cardiac magnetic resonance imaging measure of interest and the incidence of cancer, separately, for an all-inclusive cancer end point as well as prostate, breast, female-specific, colorectal, and lung cancer subtypes.
resultsOf 6214 participants with cancer data available (median age, 61.0 years; 52.7% women), 4595 had at least 1 cardiac magnetic resonance imaging-derived measure of interest, with 563 cancer events over a median follow-up of 18.7 years. Overall cancer incidence was higher with greater left ventricular mass index or left ventricular mass/volume ratio, and lower with higher left atrial emptying fraction or peak left atrial longitudinal strain. In adjusted Cox proportional hazards models, left ventricular mass index was significantly associated with the hazard of breast cancer (hazard ratio [HR], 1.88 [95% CI, 1.19-2.97];
conclusionsIn the MESA cohort, elevated left ventricular mass index and worse (lower) peak left atrial strain were associated with an increased risk of breast cancer and colorectal cancer, respectively. Subclinical cardiac remodeling may serve as an early marker to identify individuals at risk for both cardiovascular disease and cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.